Wednesday, 19 September 2018

GT Healthcare invests $26.6M in Potrero Medical

12 July 2018 | News

The funding will support further commercialization efforts of the company's flagship product, the Accuryn Monitoring System.

Image credit- medgadget.com

Image credit- medgadget.com

Potrero Medical, Inc., a predictive health company focused on using smart sensors and analytics for early detection of critical illnesses, recently announced the closing of a $26.6 million Series C financing. The financing was led by China-focused healthcare investment firm GT Healthcare Capital Partners and Silicon Valley-based Sonder Capital. The funding will support further commercialization efforts of the company's flagship product, the Accuryn Monitoring System. 

With the Accuryn Monitoring System, Potrero Medical is transforming critical care monitoring by evolving the traditional urinary catheter into a smart sensor that helps to accurately monitor patients' vital signs in real-time. The technology is the world's first commercially available system for ICU patients that can fully integrate physiological measurements for intra-abdominal pressure, urine output, and core body temperature.

The capital Potrero Medical raised will also be used in developing an artificial intelligence platform to assist physicians with early intervention of life­ threatening events, such as Acute Kidney Injury (AKI).

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Click Here!

Survey Box

Is ageing Asia spurring rise in assistive robots and tele-healthcare?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls